These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 30328143

  • 1. Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
    Kohn CG, Bunz TJ, Beyer-Westendorf J, Coleman CI.
    Eur J Haematol; 2019 Feb; 102(2):143-149. PubMed ID: 30328143
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI, Bunz TJ, Turpie AGG.
    Thromb Haemost; 2017 Oct 05; 117(10):1841-1847. PubMed ID: 28640322
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism.
    Coleman CI, Turpie AGG, Bunz TJ, Beyer-Westendorf J.
    Am J Med; 2018 Aug 05; 131(8):933-938.e1. PubMed ID: 29526541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.
    Coleman CI, Peacock WF, Bunz TJ, Beyer-Westendorf J.
    Thromb Res; 2018 Aug 05; 168():31-36. PubMed ID: 29883907
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
    Costa OS, Beyer-Westendorf J, Ashton V, Milentijevic D, Moore KT, Bunz TJ, Coleman CI.
    J Thromb Thrombolysis; 2021 Feb 05; 51(2):349-358. PubMed ID: 32588288
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ, San Agustin K, DeAngelo J, Campbell AM.
    Ann Pharmacother; 2020 Apr 05; 54(4):344-350. PubMed ID: 31672028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A, Desai A, Calixte R, Aparnath M, Hindenburg A, Salzman S, Mathew JP.
    Lung; 2016 Aug 05; 194(4):605-11. PubMed ID: 27192990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients.
    Fung KP, Chan KH, Ng V, Tsui PT, You JHS.
    Cardiovasc Drugs Ther; 2019 Jun 05; 33(3):331-337. PubMed ID: 30888571
    [Abstract] [Full Text] [Related]

  • 18. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: Complications and reversal strategies as compared to warfarin therapy.
    Myers SP, Dadashzadeh ER, Cheung J, Alarcon L, Kutcher M, Brown JB, Neal MD.
    J Trauma Acute Care Surg; 2017 Mar 05; 82(3):542-549. PubMed ID: 28045742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.